2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...

2/26/2025Former NMPA Deputy Commissioner Under Investigation

2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...

2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial

2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...

2/25/2025China Launches Flagship Hospital Alliance to Advance Integrative Medic...

2/25/2025OS Therapies Launches Subsidiary to Seek ADC Joint Ventures in US and ...

2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...

2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

2/21/2025Recent Executive Moves

2/21/2025Hengrui Medicine Advances Dual GLP-1/GIP Agonist HRS9531 with First Ph...

2/21/2025MediLink's YL217 Received FDA Clearance of IND Application

2/21/2025NMPA Announces Package Insert Revision of Fluorouracil Injection

2/21/2025Novo Nordisk Sues KBP Biosciences for $830 Million Over Alleged Fraud

2/21/2025India Can Surpass China in Drug Discovery, Says Biocon Chief

2/21/2025China Unveils 2025 Action Plan to Boost Foreign Investment in Biotech ...

2/21/2025FibroGen Sells China Subsidiary to AstraZeneca in $160 Million Deal

2/20/2025Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...

2/20/2025Ascletis Reports Positive Interim Results from U.S. Phase Ib Study of ...

2/19/2025China Holds 2025 National Drug Regulation Conference, Setting Key Prio...

2/19/2025Genuine Biotech Submits Second IPO Application amid Hong Kong Market R...

2/19/2025Pharma Industry Faces Uncertainty Amid Potential U.S. Tariffs on Chin...

Page:8/47 Total number of articles:1391: [First][<<] [6] [7] [8] [9] [10] [>>] [End]